nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Snapshot of the Evolution of Pharmaceutical Regulations in China and Hong Kong
|
Lin, Bing Bing |
|
|
44 |
5 |
p. 633-639 |
artikel |
2 |
Assessment of Consistency of Treatment Effects in Multiregional Clinical Trials
|
Quan, Hui |
|
|
44 |
5 |
p. 617-632 |
artikel |
3 |
Blinded Sample Size Recalculation in Noninferiority Trials: A Case Study in Dermatology
|
Friede, Tim |
|
|
44 |
5 |
p. 599-607 |
artikel |
4 |
Medical Liaison Survey 4: Assessing Tools Used by Medical Liaisons, Clinical Trial Involvement, and Career Strategies
|
Klinger, Craig J. |
|
|
44 |
5 |
p. 551-567 |
artikel |
5 |
Nonparametric Sample Size Estimation for Sensitivity and Specificity with Multiple Observations per Subject
|
Hu, Fan |
|
|
44 |
5 |
p. 609-616 |
artikel |
6 |
Overview and Comparison of Postmarketing Drug Safety Surveillance in Selected Developing and Well-Developed Countries
|
Vaidya, Sampada S. |
|
|
44 |
5 |
p. 519-533 |
artikel |
7 |
Pharmaceutical Medical Information Contact Centers: Results of Three Benchmarking Surveys
|
Guillot, Pete |
|
|
44 |
5 |
p. 569-579 |
artikel |
8 |
Statistical Considerations for the Efficacy Assessment of Clinical Studies of Vulvar and Vaginal Atrophy
|
Chen, Ling |
|
|
44 |
5 |
p. 581-588 |
artikel |
9 |
Statistical Inference after an Adaptive Group Sequential Design: A Case Study
|
Tremmel, Lothar T. |
|
|
44 |
5 |
p. 589-598 |
artikel |
10 |
Survey of Medical Liaison Practices 3: Assessing Practice Trends across the Pharmaceutical Industry
|
Bass, J. Lynn |
|
|
44 |
5 |
p. 535-549 |
artikel |
11 |
Understanding the Differences and Effectively Transitioning between the US Integrated Summaries of Effectiveness and Safety (ISE/ISS) and the CTD Summaries of Clinical Efficacy and Safety (SCE/SCS)
|
Schwartz, David N. |
|
|
44 |
5 |
p. 641-648 |
artikel |